Federal Register Proposed rule: FDA will hold a public meeting 12/5 to solicit comments on a 9/20 proposed rule that would amend FDA's regulation on the use of ozone-depleting substances in self- pressurized containers to remove the essential-use designation for oral pressurized metered-dose inhalers (MDIs) containing epinephrine. The meeting will be held from 9 a.m. to 3:30 p.m. at the CDER Advisory Committee Conference Room, 5630 Fishers Lane, Rm. 1066, Rockville, MD. Contact Rose Cunningham, (301) 443-5383.
The comment period on the proposed rule is extended to 12/19. To view this proposed rule, click here.